Activity Assay:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Expressing:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Binding Assay:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Incubation:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Methylation:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Residue:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Western Blot:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Gene Expression:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Control:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Staining:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
WST-1 Assay:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Cytometry:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Knockdown:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Transfection:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Negative Control:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
In Vivo:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Real-time Polymerase Chain Reaction:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
MANN-WHITNEY:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
In Vitro:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
Quantitative RT-PCR:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
MTT Assay:Article Title: KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Article Snippet: Human B—ALL cell lines SEM (RRID:CVCL_0095), RS4;11 (RRID:CVCL_0093), REH (RRID: CVCL_1650), and NALM-6 (RRID:CVCL_0092) as well as human AML lines MV4;11 (RRID: CVCL_0064), and MOLM13 (RRID:CVCL_2119) were purchased from DSMZ (Braunschweig, Germany), and maintained at 37 °C and 5% CO2 in IMDM medium (SEM), Alpha MEM medium (RS4;11), or RPMI medium (REH, NALM-6, MV4;11, MOLM13) supplemented with 10% heat-inactivated fetal calf serum, and 100 μg mL 1 penicillin/streptomycin (all PAN—biotech, Aidenbach, Germany). .. M
Article Title: A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Article Snippet: The B-ALL cell lines SEM and NALM6 were obtained from the DSMZ cell line bank (Braunschweig, Germany).. Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).Luciferase (Luc)/ GFP-expressing NALM6 cells were kindly provided by Prof. R.J. Brentjens (Memorial Sloan Kettering Cancer Center, NY, USA).
Article Title: Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Article Snippet: Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.Received 15 November 2010; revised 12 July 2011; accepted 9 August 2011; published online 21 October 2011 Correspondence: Dr RW Stam, Department of Pediatric Oncology/ Hematology, Erasmus Medical Center, Sophia Children’s Hospital, Dr Molewaterplein 50, Room: Ee15-14a, PO Box 2060, Rotterdam, Zuid-Holland, 3015 GE, Netherlands.. E-mail: r.stam@erasmusmc.nl Leukemia (2012) 26, 682–692 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu t(4;11)-positive ALL cell line models The t(4;11)-positive precursor B-ALL cell lines SEM and RS4;11 were purchased from DSMZ (Braunschweig, Germany).. Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.Both cell lines were maintained as suspension cultures in RPMI 1640 with L-Alanyl-L-Glutamine (Invitrogen, Breda, the Netherlands) supplemented with 10% FCS (Integro, Zaandam, the Netherlands), 100 IU/ml penicillin, 100mg/ml streptomycin, and 0.125 mg/ml fungizone (Invitrogen) at 37 1C in humidified air containing 5% CO2.
|